IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer
Abstract Breast cancer bone metastasis is currently incurable, ~75% of patients with late-stage breast cancer develop disease recurrence in bone and available treatments are only palliative. We have previously shown that production of the pro-inflammatory cytokine interleukin-1B (IL-1B) by breast ca...
Guardado en:
Autores principales: | Claudia Tulotta, Diane V. Lefley, Charlotte K. Moore, Ana E. Amariutei, Amy R. Spicer-Hadlington, Lewis A. Quayle, Russell O. Hughes, Khawla Ahmed, Victoria Cookson, Catherine A. Evans, Jayakumar Vadakekolathu, Paul Heath, Sheila Francis, Emmanuel Pinteaux, A. Graham Pockley, Penelope D. Ottewell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db7c85c82ea947e69d237a3402f52c96 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hår
por: Niels Kayser Nielsen
Publicado: (1999) -
Harnessing spin precession with dissipation
por: A. D. Crisan, et al.
Publicado: (2016) -
The science of harnessing light’s darkness
por: Bogdanov Andrey A., et al.
Publicado: (2021) -
Har kanon køn?
por: Brian Mikkelsen, et al.
Publicado: (2006) -
THE FACTORS OPPOSING THE IMPLEMENTATION OF INNOVATIVE AND INVESTMENT PROJECTS IN THE INDUSTRY
por: V. Mylnik, et al.
Publicado: (2016)